221 related articles for article (PubMed ID: 31100455)
41. Endoscopic Mucosal Impedance Measurements Correlate With Eosinophilia and Dilation of Intercellular Spaces in Patients With Eosinophilic Esophagitis.
Katzka DA; Ravi K; Geno DM; Smyrk TC; Iyer PG; Alexander JA; Mabary JE; Camilleri M; Vaezi MF
Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1242-1248.e1. PubMed ID: 25592662
[TBL] [Abstract][Full Text] [Related]
42. Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults.
Jones SM; Sicherer SH; Burks AW; Leung DY; Lindblad RW; Dawson P; Henning AK; Berin MC; Chiang D; Vickery BP; Pesek RD; Cho CB; Davidson WF; Plaut M; Sampson HA; Wood RA;
J Allergy Clin Immunol; 2017 Apr; 139(4):1242-1252.e9. PubMed ID: 28091362
[TBL] [Abstract][Full Text] [Related]
43. Optimal Histologic Cutpoints for Treatment Response in Patients With Eosinophilic Esophagitis: Analysis of Data From a Prospective Cohort Study.
Reed CC; Wolf WA; Cotton CC; Rusin S; Perjar I; Hollyfield J; Woosley JT; Shaheen NJ; Dellon ES
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):226-233.e2. PubMed ID: 28987502
[TBL] [Abstract][Full Text] [Related]
44. A Novel Allergen-Specific Immune Signature-Directed Approach to Dietary Elimination in Eosinophilic Esophagitis.
Dellon ES; Guo R; McGee SJ; Hamilton DK; Nicolai E; Covington J; Moist SE; Arrington A; Wright BL; Burks AW; Vickery BP; Kulis M
Clin Transl Gastroenterol; 2019 Dec; 10(12):e00099. PubMed ID: 31789931
[TBL] [Abstract][Full Text] [Related]
45. High Prevalence of Response to Proton-pump Inhibitor Treatment in Children With Esophageal Eosinophilia.
Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Quevedo S; Bracamonte T; Román E
J Pediatr Gastroenterol Nutr; 2016 May; 62(5):704-10. PubMed ID: 26513622
[TBL] [Abstract][Full Text] [Related]
46. Comparison of mucosal impedance measurements throughout the esophagus and mucosal eosinophil counts in endoscopic biopsy specimens in eosinophilic esophagitis.
Alexander JA; Ravi K; Geno DM; Tholen CJ; Higginbotham TC; Wildhorn S; Camilleri M; Vaezi MF; Katzka DA
Gastrointest Endosc; 2019 Apr; 89(4):693-700.e1. PubMed ID: 30145316
[TBL] [Abstract][Full Text] [Related]
47. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA
Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599
[TBL] [Abstract][Full Text] [Related]
48. Clinical Features at Baseline Cannot Predict Symptom Response to Placebo in Patients With Eosinophilic Esophagitis.
Hirano I; Dellon ES; Collins MH; Williams J; Lan L; Katzka DA
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2126-2128.e1. PubMed ID: 30502508
[TBL] [Abstract][Full Text] [Related]
49. RNA sequencing identifies global transcriptional changes in peripheral CD4
Ruffner MA; Zhang Z; Maurer K; Muir AB; Cianferoni A; Sullivan KE; Spergel JM
Clin Transl Immunology; 2021; 10(7):e1314. PubMed ID: 34322233
[TBL] [Abstract][Full Text] [Related]
50. Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease.
Lucendo AJ; Arias Á; González-Cervera J; Yagüe-Compadre JL; Guagnozzi D; Angueira T; Jiménez-Contreras S; González-Castillo S; Rodríguez-Domíngez B; De Rezende LC; Tenias JM
J Allergy Clin Immunol; 2013 Mar; 131(3):797-804. PubMed ID: 23375693
[TBL] [Abstract][Full Text] [Related]
51. Clinical presentation of patients with eosinophilic inflammation of the esophagus.
Baxi S; Gupta SK; Swigonski N; Fitzgerald JF
Gastrointest Endosc; 2006 Oct; 64(4):473-8. PubMed ID: 16996334
[TBL] [Abstract][Full Text] [Related]
52. Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results.
Fleischer DM; Shreffler WG; Campbell DE; Green TD; Anvari S; Assa'ad A; Bégin P; Beyer K; Bird JA; Brown-Whitehorn T; Byrne A; Chan ES; Cheema A; Chinthrajah S; Chong HJ; Davis CM; Ford LS; Gagnon R; Greenhawt M; Hourihane JO; Jones SM; Kim EH; Lange L; Lanser BJ; Leonard S; Mahler V; Maronna A; Nowak-Wegrzyn A; Oriel RC; O'Sullivan M; Petroni D; Pongracic JA; Prescott SL; Schneider LC; Smith P; Staab D; Sussman G; Wood R; Yang WH; Lambert R; Peillon A; Bois T; Sampson HA
J Allergy Clin Immunol; 2020 Oct; 146(4):863-874. PubMed ID: 32659313
[TBL] [Abstract][Full Text] [Related]
53. Eosinophilic Esophagitis and Gastroenteritis.
Cianferoni A; Spergel JM
Curr Allergy Asthma Rep; 2015 Sep; 15(9):58. PubMed ID: 26233430
[TBL] [Abstract][Full Text] [Related]
54. Histopathologic variability in children with eosinophilic esophagitis.
Shah A; Kagalwalla AF; Gonsalves N; Melin-Aldana H; Li BU; Hirano I
Am J Gastroenterol; 2009 Mar; 104(3):716-21. PubMed ID: 19209168
[TBL] [Abstract][Full Text] [Related]
55. Recent advances in epicutaneous immunotherapy and potential applications in food allergy.
Hervé PL; Dioszeghy V; Matthews K; Bee KJ; Campbell DE; Sampson HA
Front Allergy; 2023; 4():1290003. PubMed ID: 37965375
[TBL] [Abstract][Full Text] [Related]
56. Endoscopic appearance and location dictate diagnostic yield of biopsies in eosinophilic oesophagitis.
Salek J; Clayton F; Vinson L; Saffari H; Pease LF; Boynton K; Fang J; Cox K; Peterson KA
Aliment Pharmacol Ther; 2015 Jun; 41(12):1288-95. PubMed ID: 25898774
[TBL] [Abstract][Full Text] [Related]
57. The Efficacy and Safety of Epicutaneous Immunotherapy for Allergic Diseases: A Systematic Review and Meta-Analysis.
Xiong L; Lin J; Luo Y; Chen W; Dai J
Int Arch Allergy Immunol; 2020; 181(3):170-182. PubMed ID: 31801149
[TBL] [Abstract][Full Text] [Related]
58. Use of the Esophageal Sponge in Directing Food Reintroduction in Eosinophilic Esophagitis.
Alexander JA; Ravi K; Symrk TC; Wu TT; Lavey CJ; Geno D; Johnson AJ; Lennon RJ; Collins MH; Dellon ES; Katzka DA
Clin Gastroenterol Hepatol; 2023 Feb; 21(2):299-306.e3. PubMed ID: 35697266
[TBL] [Abstract][Full Text] [Related]
59. Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis.
Dellon ES; Collins MH; Rothenberg ME; Assouline-Dayan Y; Evans L; Gupta S; Schoepfer A; Straumann A; Safroneeva E; Rodriguez C; Minton N; Hua SY; Hirano I
Clin Gastroenterol Hepatol; 2021 Mar; 19(3):473-483.e17. PubMed ID: 32205221
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of a 4-Food Elimination Diet for Children With Eosinophilic Esophagitis.
Kagalwalla AF; Wechsler JB; Amsden K; Schwartz S; Makhija M; Olive A; Davis CM; Manuel-Rubio M; Marcus S; Shaykin R; Sulkowski M; Johnson K; Ross JN; Riffle ME; Groetch M; Melin-Aldana H; Schady D; Palac H; Kim KA; Wershil BK; Collins MH; Chehade M
Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1698-1707.e7. PubMed ID: 28603055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
